Coronavirus

The 7 hardest-hit states all have mortality rates between 113% and 172% higher than normal, while New York City’s death rate is 325% higher than usual.

Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.

The MVA-MERS-S vaccine is based on an attenuated virus, modified vaccinia virus Ankara, which had previously been used in a smallpox eradication vaccination campaign.

There continues to be a debate in the scientific community about the role that angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play in coronavirus disease 2019 infection.

Join expert faculty members as they discuss the vital role of pharmacists during the COVID-19 pandemic.

Interferons are being investigated as a possible treatment for COVID-19, but their effects are not yet clear.

Pharmacist Moms Group founder Suzanne Soliman, PharmD, BCMAS, speaks on the power of social media in the field of pharmacy in the age of COVID-19.

Although data for adult patients with coronavirus disease 2019 (COVID-19) have been widely available, limited reports have been analyzed regarding pediatric patients infected with SARS-CoV-2, according to the study authors.

Hydroxychloroquine and remdesivir have been caught up in the rush to develop an effective treatment for COVID-19.

Nancy Lyons, BSPharm, MBA, CDE, chief pharmacist of McKesson Health Mart, discusses how community pharmacists can prepare for the expansion of COVID-19 testing.

Adam Martin, PharmD, discusses how to remain healthy and motivated during the COVID-19 pandemic.

The Alliance for Pharmacy Compounding created the tool to help address a need for drugs to treat patients with COVID-19.

The era of social distancing will likely leave a lasting impression on telehealth services, as HCPs quickly learn to incorporate it as a valuable tool and adapt to changes.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

The current state of oncology is shaping challenges for the future specifically in the areas of telehealth, home infusions, and a surge of new patients that have not been to oncology clinics yet.

Panic and a host of interactions are entwined with disease-modifying antirheumatic drugs.

Experts discuss what their teams have learned throughout the COVID-19 pandemic, during the COA virtual conference.

Solving challenges of the current system is vital to spreading clinical trials into community clinics, which may be increasingly important.

Patients with cardiovascular disease who develop COVID-19 have a higher risk of mortality, according to a SCAI press release.

With additional state action to remove testing restrictions, pharmacists will be able to continue their work to serve on the frontlines of health care during this pandemic.

Two case studies have highlighted the use of tele-diabetes to manage new-onset type 1 diabetes (T1D) cases in an adult and an infant during the coronavirus disease 2019 (COVID-19) pandemic.

A new study indicates that treatment with hydroxychloroquine increases overall mortality in patients hospitalized with COVID-19.

The FDA has approved the first diagnostic test with a home collection option for the coronavirus disease 2019.

The new guidance authorizes licensed pharmacists to order and administer COVID-19 tests, including serology tests, that are approved by the FDA.

Pharmacy Times® invites you to join us and experts in pharmacy to gain insight into the value pharmacists provide in treating patients throughout the pandemic.

More than 53% of survey respondents reported having a diversion event within the last year, in addition to 37% who were aware of at least 1 colleague who has diverted controlled substances.

Oncology/Hematology pharmacists from Boston Medical Center discuss how COVID-19 has affected their patients.

Today, we’re thanking Angela Garcia, PharmD, MPH, CPh, for her work as an American Pharmacists Association–Academy of Student Pharmacists (APhA-ASP) chapter advisor.

An overview of the most recent legal developments related to COVID-19 that are relevant to pharmacies.

Widely used medications for patients with HIV/AIDS may be potential treatments for the coronavirus disease 2019 should the drugs demonstrate safety and efficacy in clinical trials.